Search

Author/Creator Arribas, Jose

1. Evolution of Protease Inhibitor Resistance in Human Immunodeficiency Virus Type 1 Infected Patients Failing Protease Inhibitor Monotherapy as Second-line Therapy in Low-income Countries: An Observational Analysis Within the EARNEST Randomized Trial. (28th July 2018)

Authors:
Thompson, Jennifer A; Kityo, Cissy; Dunn, David; Hoppe, Anne; Ndashimye, Emmanuel; Hakim, James; Kambugu, Andrew; van Oosterhout, Joep J; Arribas, Jose; Mugyenyi, Peter; Walker, A Sarah; Paton, Nicholas I
Journal:
Clinical infectious diseases
Issue:
Volume 68:Number 7(2019)
Page Start:
1184
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. P045 Switching from boosted atazanavir (ATV) plus FTC/TDF to a TAF-based single tablet regimen (STR): week 48 data in virologically suppressed adults. (30th June 2016)

Authors:
Orkin, Chloe; Rjinders, Bart; Stephan, Christoph; McKellar, Mehri; Kiertiburanakul, Sasisopin; Arribas, Jose; Murphy, Daniel; Bloch, Mark; Liu, YaPei; Fordyce, Marshall; Yau, Stuart; McCallister, Scott
Journal:
Sexually transmitted infections
Issue:
Volume 92(2016)Supplement 1
Page Start:
A34
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial. Issue 5 (May 2021)

Authors:
Lescure, François-Xavier; Honda, Hitoshi; Fowler, Robert A; Lazar, Jennifer Sloane; Shi, Genming; Wung, Peter; Patel, Naimish; Hagino, Owen; Bazzalo, Ignacio J.; Casas, Marcelo M.; Nuñez, Sebastián A.; Pere, Yael; Ibarrola, Carlos M.; Solis Aramayo, Marco A.; Cuesta, Maria C.; Duarte, Andrea E.; ...
Journal:
Lancet
Issue:
Volume 9:Issue 5(2021)
Page Start:
522
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗